Autoimmune Diseases  >>  AC430  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AC430 / Daiichi Sankyo
NCT01287858: Study to Assess Safety, Tolerability, and Pharmacokinetics of Oral Doses for AC430 in Healthy Subjects

Completed
1
88
US
AC430
Daiichi Sankyo, Inc.
Rheumatoid Arthritis
06/11
06/11

Download Options